|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/42 | |
| C07K 16/32 |
| (11) | Patento numeris | 3046583 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14845738.5 |
| Europos patento paraiškos padavimo data | 2014-09-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/056412 |
| Data | 2014-09-18 |
| (87) | Numeris | WO 2015/042325 |
| Data | 2015-03-26 |
| (30) | Numeris | Data | Šalis |
| 201361879627 P | 2013-09-18 | US |
| (72) |
DE LOS PINOS, Elisabet, US
SCHILLER, John, T., US
KINES, Rhonda, C., US
MACDOUGALL, John, US
|
| (73) |
Aura Biosciences, Inc.,
85 Bolton Street, Cambridge, MA 02140,
US
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, Maryland 20892-7660, US |
| (54) | VIRUS-LIKE PARTICLE CONJUGATES FOR TREATMENT OF TUMORS |
| VIRUS-LIKE PARTICLE CONJUGATES FOR TREATMENT OF TUMORS |